Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 4 1

Status

Terminated 2Completed 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 2NIH 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Papillomavirus Infections 3Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Transplant-Related Cancer 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Hepatitis A Vaccines × Clear all
NCT01824537 2025-03-19

TRAP-HPV

McGill University

Phase 4 Completed
372 enrolled 12 charts

Papillomavirus Infections

NCT01282216 2019-05-30

Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
120 enrolled 5 charts

Transplant-Related Cancer

NCT01339000 2016-06-22

Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
1 enrolled 5 charts
BreastGastrointestinalGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Colonic Neoplasms, Colorectal Neoplasms

NCT02082639 2015-07-20

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years

GlaxoSmithKline

Phase 3 Withdrawn

Papillomavirus Infections

NCT00316706 2012-09-18

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

GlaxoSmithKline

Phase 3 Completed
1,245 enrolled 11 charts
Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡